Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385969204> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W4385969204 abstract "To date, it is still unknown whether orodispersible tablet (ODT) ticagrelor might represent a suitable way to reach a proper antiaggregation in acute coronary syndrome (ACS) patients receiving morphine. Aim of the present study was to evaluate platelet inhibition with 180 mg ticagrelor loading dose (LD) administered as ODT compared with standard coated tablet ticagrelor formulation in ACS patients undergoing percutaneous coronary intervention (PCI) according to morphine use.One-hundred and 30 patients presenting with STEMI or very high-risk NSTE-ACS were randomly assigned to receive ODT or standard ticagrelor LD. Potential morphine-ticagrelor interaction was assessed by stratified randomization according to morphine use. Platelet reactivity was evaluated by Platelet Reactivity Units (PRU) VerifyNow™ฏ 1, 2, 4 and 6 hours after ticagrelor LD. The primary endpoint was residual platelet reactivity 1 hour after LD across the two ticagrelor formulation and according to morphine use. Safety endpoints were major bleedings and other in-hospital ticagrelor administration-related adverse events. One hour after LD, PRU median value was higher in morphine-treated patients (N=32) as compared with patients not receiving morphine (N=98; PRU= 187 [70-217]) vs 73 [7-187]; p=0.012). In patients with morphine, 1-hour PRU values were similar between study groups (192 [114-236] vs 173 [16-215] in ODT and standard tablet ticagrelor, respectively). Similarly, in patients without morphine, 1-hour PRU values were not significantly different between study groups (69 [8-152] vs 110 [6 - 193] in ODT and standard tablet ticagrelor, respectively). Platelet reactivity appeared similar in the 2 study arms at 2, 4 and 6 hours after LD. No significant difference was observed among patients with or without morphine regarding in-hospital adverse events or drug side-effects, even if a reinfarction due to acute stent thrombosis was observed in a patient treated with morphine.There was no difference between ODT and standard ticagrelor tablets in terms of post-LD residual platelet reactivity, percentage of platelet inhibition or safety regardless to morphine use." @default.
- W4385969204 created "2023-08-19" @default.
- W4385969204 creator A5004617206 @default.
- W4385969204 creator A5008352332 @default.
- W4385969204 creator A5017330710 @default.
- W4385969204 creator A5029975658 @default.
- W4385969204 creator A5040053463 @default.
- W4385969204 creator A5050054921 @default.
- W4385969204 creator A5057085855 @default.
- W4385969204 creator A5062552702 @default.
- W4385969204 creator A5069989968 @default.
- W4385969204 creator A5077517566 @default.
- W4385969204 creator A5086328813 @default.
- W4385969204 creator A5091627911 @default.
- W4385969204 date "2023-08-17" @default.
- W4385969204 modified "2023-10-08" @default.
- W4385969204 title "Platelet inhibition with orodispersible ticagrelor in acute coronary syndromes according to morphine use: the TASTER study final results" @default.
- W4385969204 cites W1898583860 @default.
- W4385969204 cites W2122776876 @default.
- W4385969204 cites W2122779695 @default.
- W4385969204 cites W2137746198 @default.
- W4385969204 cites W2140501627 @default.
- W4385969204 cites W2146338929 @default.
- W4385969204 cites W2170029016 @default.
- W4385969204 cites W2199344134 @default.
- W4385969204 cites W2288863650 @default.
- W4385969204 cites W2338475291 @default.
- W4385969204 cites W2402119165 @default.
- W4385969204 cites W2472791408 @default.
- W4385969204 cites W2751685853 @default.
- W4385969204 cites W2766674394 @default.
- W4385969204 cites W3046432421 @default.
- W4385969204 cites W3104465182 @default.
- W4385969204 cites W3162195278 @default.
- W4385969204 cites W3180892105 @default.
- W4385969204 cites W9177793 @default.
- W4385969204 doi "https://doi.org/10.1093/ehjcvp/pvad061" @default.
- W4385969204 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37591636" @default.
- W4385969204 hasPublicationYear "2023" @default.
- W4385969204 type Work @default.
- W4385969204 citedByCount "0" @default.
- W4385969204 crossrefType "journal-article" @default.
- W4385969204 hasAuthorship W4385969204A5004617206 @default.
- W4385969204 hasAuthorship W4385969204A5008352332 @default.
- W4385969204 hasAuthorship W4385969204A5017330710 @default.
- W4385969204 hasAuthorship W4385969204A5029975658 @default.
- W4385969204 hasAuthorship W4385969204A5040053463 @default.
- W4385969204 hasAuthorship W4385969204A5050054921 @default.
- W4385969204 hasAuthorship W4385969204A5057085855 @default.
- W4385969204 hasAuthorship W4385969204A5062552702 @default.
- W4385969204 hasAuthorship W4385969204A5069989968 @default.
- W4385969204 hasAuthorship W4385969204A5077517566 @default.
- W4385969204 hasAuthorship W4385969204A5086328813 @default.
- W4385969204 hasAuthorship W4385969204A5091627911 @default.
- W4385969204 hasConcept C126322002 @default.
- W4385969204 hasConcept C2777389121 @default.
- W4385969204 hasConcept C2777698277 @default.
- W4385969204 hasConcept C2780400711 @default.
- W4385969204 hasConcept C2780890252 @default.
- W4385969204 hasConcept C42219234 @default.
- W4385969204 hasConcept C500558357 @default.
- W4385969204 hasConcept C71924100 @default.
- W4385969204 hasConcept C89560881 @default.
- W4385969204 hasConcept C98274493 @default.
- W4385969204 hasConceptScore W4385969204C126322002 @default.
- W4385969204 hasConceptScore W4385969204C2777389121 @default.
- W4385969204 hasConceptScore W4385969204C2777698277 @default.
- W4385969204 hasConceptScore W4385969204C2780400711 @default.
- W4385969204 hasConceptScore W4385969204C2780890252 @default.
- W4385969204 hasConceptScore W4385969204C42219234 @default.
- W4385969204 hasConceptScore W4385969204C500558357 @default.
- W4385969204 hasConceptScore W4385969204C71924100 @default.
- W4385969204 hasConceptScore W4385969204C89560881 @default.
- W4385969204 hasConceptScore W4385969204C98274493 @default.
- W4385969204 hasFunder F4320307105 @default.
- W4385969204 hasFunder F4320307770 @default.
- W4385969204 hasFunder F4320307771 @default.
- W4385969204 hasFunder F4320332932 @default.
- W4385969204 hasLocation W43859692041 @default.
- W4385969204 hasLocation W43859692042 @default.
- W4385969204 hasOpenAccess W4385969204 @default.
- W4385969204 hasPrimaryLocation W43859692041 @default.
- W4385969204 hasRelatedWork W1967777347 @default.
- W4385969204 hasRelatedWork W2106217940 @default.
- W4385969204 hasRelatedWork W2134849884 @default.
- W4385969204 hasRelatedWork W2150858828 @default.
- W4385969204 hasRelatedWork W2160952754 @default.
- W4385969204 hasRelatedWork W2333058653 @default.
- W4385969204 hasRelatedWork W2538235438 @default.
- W4385969204 hasRelatedWork W2759749682 @default.
- W4385969204 hasRelatedWork W3119665449 @default.
- W4385969204 hasRelatedWork W3129961335 @default.
- W4385969204 isParatext "false" @default.
- W4385969204 isRetracted "false" @default.
- W4385969204 workType "article" @default.